Plasma steroid concentrations reflect acute disease severity and normalise during recovery in people hospitalised with COVID-19.
Devine K, Russell CD, Blanco GR, Walker BR, Homer NZM, Denham SG, Simpson JP, Leavy OC, Elneima O, McAuley HJC, Shikotra A, Singapuri A, Sereno M, Saunders RM, Harris VC, Houchen-Wolloff L, Greening NJ, Lone NI, Thorpe M, Greenhalf W, Chalmers JD, Ho LP, Horsley A, Marks M, Raman B, Moore SC, Dunning J, Semple MG, Andrew R, Wain LV, Evans RA, Brightling CE, Kenneth Baillie J, Reynolds RM; ISARIC4C Investigators and PHOSP-COVID Study Collaborative Group.
Devine K, et al.
Clin Endocrinol (Oxf). 2024 Apr;100(4):317-327. doi: 10.1111/cen.15012. Epub 2024 Jan 17.
Clin Endocrinol (Oxf). 2024.
PMID: 38229583
OBJECTIVE: Endocrine systems are disrupted in acute illness, and symptoms reported following coronavirus disease 2019 (COVID-19) are similar to those found with clinical hormone deficiencies. We hypothesised that people with severe …
OBJECTIVE: Endocrine systems are disrupted in acute illness, and symptoms reported following coronavirus disease 201 …